Chapter
Section I : Physicochemical Factors In Relation To Biological Activity Of Drugs
Nature as a Source of Drug Compounds
Plant-Derived Bioactive Materials
Microbial Species with Bioactive Metabolites
Marine Invertebrates as a Source of Bioactive Compounds
Chemical Diversity of Natural Products
Methodologies in Natural Product Drug Discovery
Identification of Biologically Active Material
Computer-Assisted Drug Design
Chapter 1 - Physicochemical Properties
Chapter 2 - Ferguson Principle
Chapter 3 - Hydrogen Bonding
Chapter 4 - Ionization and pKa Value
Drug Exerting Action as Undissociated Molecules
Drug Exerting Action as Ionized Molecules
Chapter 5 - Redox Potential
Chapter 6 - Surface Tension
Chapter 8 - Steric Features of Drugs
Reasons Behind Varying Activity of Optical Isomers
Binding of Enantiomers to Receptors
Chapter 9 - Bioisosterism
Chapter 1 - Concepts of Drug Design
Design of Analogues and Prodrugs
Design of Lead and Lead Discovery
Approaches to Lead Discovery
Drug Design Through Disjunction
Drug Design Through Conjunction
Molecular Hybridization in Drug Design
Rational Approach to Drug Design
Macromolecular Perturbation Theory
Activation-Aggregation Theory
Forces Involved in Drug Receptors Interaction
Dipole-Dipole and Ion-Dipole Interactions
van der Waal's or London Dispersion Forces
Factors Affecting the Drug-Receptor Interaction
Chapter 3 - Computer-Aided Drug Design
Chapter 4 - Structure-Activity Relationship and Quantitative Structure-Activity Relationship
Historical Development of QSAR
Basic Requirements for QSAR Analysis
Steps Involved in QSAR Studies
Statistical Methods Used in QSAR Analysis
Partial Least Square (PLS)
Genetic Function Approximation (GFA)
Genetic Partial Least Squares (G/PLSs)
Principal Component Analysis (PCA)
Statistical Measures Commonly Used in Regression Analysis
Model Development Procedures
Classical or 2D QSAR Analysis
Comparative Molecular Field Analysis (CoMFA)
Comparative Molecular Similarity Indices Analysis (CoMSIA)
Chapter 5 - Combinatorial Chemistry
Principles of Combinatorial Chemistry
Combinatorial Compound Libraries
Combinatorial Synthesis on Solid Phase
Advantages and Disadvantages of Solid Support Reagents
Classification of Pro-Drug
Enhancement of Bio-Availability (Lipophilicity)
Improvement of Stability and Solubility
Decreased Toxicity and Adverse Reactions
Site-Specific Drug Delivery
Increased duration of action
Section III : Drugs Acting Oncentral Nervoussystem
Chapter 1 - Central Nervous System
Adrenergic Pathway in CNS
Functional Aspects of Dopamine
Functional Aspects of 5-HT
Cholinergic Transmission in CNS
Other Neurotransmitters and Functions in CNS
Chapter 2 - Sedatives and Hypnotics
Treatment of Anxiety States
Treatment of Sleep Problems
Molecular Basis of Inhibitory Neurotransmitters
Synthesis and Drug Profile
Chapter 3 - General Anaesthetics
Types of General Anaesthetics
Synthesis and Drug Profile
Chapter 4 - Local Anaesthetics
Synthesis and Drug Profile
Sar of Benzoic Acid Derivatives
Chapter 5 - Tranquillizers
-->Synthesis and drug profile
Chapter 6 - Antidepressants
Synthesis and drug profile
-->SAR of Dibenzo Cycloheptane Derivatives
Chapter 7 - CNS Stimulants
Synthesis and Drug Profile
Chapter 8 - Narcotic Analgesics
Synthesis and Drug Profile
SAR of Meperidine Analogues
SAR of Diphenyl Heptanone (Methadone Series)
SAR of Benzomorphan Derivatives (Benzazocines)
Chapter 9 - Anticonvulsants
Pharmalocogical Classification
Synthesis and Drug Profile
Chapter 10 - Antiparkinsonism Agents
Synthesis and Drug Profile
Chapter 11 - Skeletal Muscle Relaxants
Synthesis and Drug Profile
Chapter 12 - Alzheimers Disease
Acetylcholinesterase Inhibitors
Section IV : Drugs Acting Onautonomic Nervoussystem
Chapter 1 - Autonomic Nervous System
Regulation of Catecholamines
Chapter 2 - Adrenergic Drugs
Physiological Basis of Adrenergic Receptor Function
Mechanism of Action of Sympathomimetics
1 Adrenergic Receptor Action
2 Adrenergic Receptor Action
1 Adrenergic Receptor Action
2 Adrenergic Receptor Action
General Classification of Adrenerigic Agonists
Classifications Based on Therapeutic Uses
Classification Based on Chemical Structures
Synthesis and Drug Profile
Structural-Activity Relationship
Chapter 3 - Cholinergic Drugs
Spectrum of Cholinomimetic Drugs
Direct-acting Cholinoceptor Stimulants
Mechanism of Action of Directly Acting Cholinergic Drugs
Indirect Acting Cholinomimetic Drugs
Mechanism of Action of Indirectly Acting Cholinergic Drugs (Anticholinesterase Agents)
Synthesis and Drug Profile
Structure Activity Relationship
Chapter 4 - Adrenergic Blockers
Physiological Basis of Adrenergic Receptor Antagonists
Mechanism of Action of -Adrenergic Blockers
Mechanism of Action of -Adrenergic Receptor Blockers
Synthesis and Drug Profile
Structure-Activity Relationship
Chapter 5 - Anticholinergic Drugs
Difference Between the Quaternary and the Tertiary Antimuscarinics
Synthesis and Drug Profile
SAR Solanaceous Alkaloids (Atropine Analogues)
SAR of Muscarinic Antagonists
Section V : Drugs Acting Oncardiovascularsystem
Chapter 1 - Cardiovascular System
Aetiology of Hypertension
Normal Regulation of Blood Pressure
Chapter 2 - Antihypertensive Drugs
Synthesis and Drug Profile
Chapter 3 - Antiarrhythmic Drugs
Synthesis and Drug Profile
Chapter 4 - Antihyperlipidaemic Agents
Synthesis and Drug Profile
Principles of Therapy for Angina
Synthesis and Drug Profile
Second-Generation Alkyl Amine Type Calcium Channel Blockers
Section VI : Drugs Acting Onurinary System
Chapter 1 - Urinary System
Functions of Renal System
Principle of Glomerular Filtration
Principle of Tubular Reabsorption and Secretion
Synthesis and Drug Profile
SAR of Thiazide Diruretics